The above observations reveal a characteristic pattern of serum AGP glycosylation in severe COVID-19, reflecting abnormalities related to the biological role of this glycoprotein during inflammation, which is also an inherent attribute of SARS-CoV-2 infection. This evidence concerns the gene ATP5MK and COVID-19.